Vitamin D supplementation and the maintenance of sufficient vitamin D levels may improve foot pain in patients with symptomatic knee osteoarthritis (OA), according to study results published in Arthritis Care & Research.
The objective of the post-hoc analysis from a randomized double-blind placebo-controlled trial (Vitamin D Effect on Osteoarthritis Study; ClinicalTrials.gov Identifier: NCT01176344) was to assess the potential benefits of vitamin D supplementation and the maintenance of sufficient vitamin D levels for foot pain in patients with symptomatic knee OA.
Researchers enrolled 413 patients (mean age, 63.2 years; 49.7% women) with symptomatic knee OA and serum 25-hydroxyvitamin D levels between 12.5 and 60 nmol/L. A total of 340 patients completed the study. The study participants were randomly assigned to monthly vitamin D3 treatment or placebo, over 2 years. Researchers used the Manchester Foot Pain and Disability Index (MFPDI) to assess foot pain.
At baseline, the mean MFPDI score was 22.8±7.3; 214 patients reported foot pain, including 98 (23.7%) who had disabling foot pain according to the MFPDI case definition. In the group of patients who received vitamin D, MFPDI scores did not significantly change over the study period (-0.03; 95% CI, -0.80 to 0.74), but these scores worsened in the placebo group (1.30; 95% CI, 0.51-2.09; P =.013). Furthermore, MFPDI scores decreased in patients who maintained sufficient vitamin D levels and increased in those who were not maintaining sufficient vitamin D levels over 2 years (-0.09 [95% CI, -0.79 to 0.61] vs 2.19 [95% CI, 1.21-3.18], respectively; P =.001). The decrease in MFPDI scores was greater among patients with disabling foot pain at baseline who maintained vs did not maintain sufficient vitamin D levels (-4.63 [95% CI, -6.35 to -2.92] vs -0.14 [95% CI, -2.75 to 2.48], respectively; P =.005).
Today’s Top Picks for You on Rheumatology Advisor Vitamin D Deficiency Predicts Greater Disease Activity in Early RAHigher BMI Associated With Reduced Foot Health in Patients With Rheumatoid ArthritisPain and Fatigue in PsA Linked to Reduced Quality of Life, Physical Function, and Work Productivity
Among participants who were men, the MFPDI scores improved significantly with vitamin D supplements compared with placebo. However, there was no significant interaction between sex and vitamin D supplementation or maintaining sufficient vitamin D levels in terms of change in MFPDI scores.
The study had several limitations, including those secondary to a post-hoc analysis, lack of data on the clinical importance of the differences in MFPDI scores, and potential underestimation of the benefits of vitamin D, as >60% of patients in placebo group had sufficient vitamin D levels at the end of follow-up.
“Vitamin D supplementation and maintaining sufficient vitamin D level may improve foot pain in patients [with] knee OA,” concluded the researchers.
Tu L, Zheng S, Cicuttini F, et al. Effects of vitamin D supplementation on disabling foot pain in patients with symptomatic knee osteoarthritis[published online Jul 5, 2020]. Arthritis Care Res (Hoboken). doi:10.1002/acr.24371